Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects

Parkinson's Disease (PD) is currently considered a systemic neurodegenerative disease manifested with not only motor but also non-motor symptoms. In particular, weight loss and malnutrition, a set of frequently neglected non-motor symptoms, are indeed negatively associated with the life quality of PD patients. Moreover, comorbidity of weight loss and malnutrition may impact disease progression, giving rise to dyskinesia, cognitive decline and orthostatic hypotension, and even resulting in disability and mortality. Nevertheless, the underlying mechanism of weight loss and malnutrition in PD remains obscure and possibly involving multitudinous, exogenous or endogenous, factors. What is more, there still does not exist any weight loss and malnutrition appraision standards and management strategies. Given this, here in this review, we elaborate the weight loss and malnutrition study status in PD and summarize potential determinants and mechanisms as well. In conclusion, we present current knowledge and future prospects of weight loss and malnutrition in the context of PD, aiming to appeal clinicians and researchers to pay a closer attention to this phenomena and enable better management and therapeutic strategies in future clinical practice.

[1]  B. Vellas,et al.  Weight loss in Alzheimer disease. , 2000, The American journal of clinical nutrition.

[2]  Rosanna Abbate,et al.  Adherence to Mediterranean diet and health status: meta-analysis , 2008, BMJ : British Medical Journal.

[3]  K. Kashihara Weight loss in Parkinson’s disease , 2006, Journal of Neurology.

[4]  M. Unosson,et al.  Does l‐dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease? , 2005, Acta neurologica Scandinavica.

[5]  K. Krogh Gastrointestinal Dysfunction in Parkinson’s Disease , 2011 .

[6]  Klaus Mewes,et al.  Randomized trial of pallidotomy versus medical therapy for Parkinson's disease , 2003, Annals of neurology.

[7]  H. Przuntek,et al.  Predictors of gastric emptying in Parkinson's disease , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[8]  C. Tanner,et al.  Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience. , 2012, Parkinsonism & related disorders.

[9]  K. Chan,et al.  Mitochondrial Uncoupling Protein-2 (UCP2) Mediates Leptin Protection Against MPP+ Toxicity in Neuronal Cells , 2009, Neurotoxicity Research.

[10]  M. Katsuno,et al.  Lower body mass index is associated with orthostatic hypotension in Parkinson's disease , 2017, Journal of the Neurological Sciences.

[11]  Christian Plewnia,et al.  Deep-brain-stimulation does not impair deglutition in Parkinson's disease. , 2012, Parkinsonism & related disorders.

[12]  S. Kish,et al.  Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects , 1994, Brain Research.

[13]  Johanna G. Kalf SP MSc,et al.  Impact of drooling in Parkinson’s disease , 2007, Journal of Neurology.

[14]  D. Ryglewicz,et al.  Taste responses in patients with Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  A. Westergren,et al.  Weight stability in Parkinson's disease , 2016, Nutritional neuroscience.

[16]  M. Unosson,et al.  Avoidance of solid food in weight losing older patients with Parkinson's disease. , 2006, Journal of clinical nursing.

[17]  Yaakov Stern,et al.  Dementia in Parkinson's disease , 1994, Neurology.

[18]  Nikolaus R. McFarland,et al.  Weight Loss and Impact on Quality of Life in Parkinson’s Disease , 2015, PloS one.

[19]  F. You,et al.  The stimulatory effect of neuropeptide Y on growth hormone expression, food intake, and growth in olive flounder (Paralichthys olivaceus) , 2017, Fish Physiology and Biochemistry.

[20]  H. Maas,et al.  Assessment and treatment of malnutrition in Dutch geriatric practice: consensus through a modified Delphi study. , 2012, Age and ageing.

[21]  R. Roth,et al.  Ghrelin Promotes and Protects Nigrostriatal Dopamine Function via a UCP2-Dependent Mitochondrial Mechanism , 2009, The Journal of Neuroscience.

[22]  T. Hummel,et al.  Olfactory disorders: the patients' view. , 2009, Rhinology.

[23]  O. Rascol,et al.  Parkinson's disease and weight loss: A study with anthropometric and nutritional assessment , 1992, Clinical Autonomic Research.

[24]  A. Tomkins,et al.  Increased energy expenditure in Parkinson's disease. , 1990, BMJ.

[25]  Dan Chen,et al.  Contra-directional Coupling of Nur77 and Nurr1 in Neurodegeneration: A Novel Mechanism for Memantine-Induced Anti-inflammation and Anti-mitochondrial Impairment , 2016, Molecular Neurobiology.

[26]  E. Poehlman,et al.  Free-living Daily Energy Expenditure in Patients with Parkinson's Disease , 1997, Neurology.

[27]  K. Lyons,et al.  MDS-UPDRS to assess non-motor symptoms after STN DBS for Parkinson's disease , 2016, The International journal of neuroscience.

[28]  Chris Zarow,et al.  Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. , 2003, Archives of neurology.

[29]  P. Medcalf,et al.  Fracture rates in Parkinson's disease compared with age- and gender-matched controls: a retrospective cohort study. , 2005, Age and ageing.

[30]  Andrea Mauri,et al.  Special low‐protein foods ameliorate postprandial off in patients with advanced Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[31]  J. Johanson,et al.  Chronic constipation: a survey of the patient perspective , 2007, Alimentary pharmacology & therapeutics.

[32]  M. Lanotte,et al.  Motor and Nonmotor Symptom Follow-Up in Parkinsonian Patients after Deep Brain Stimulation of the Subthalamic Nucleus , 2007, European Neurology.

[33]  Erkki Tukiainen,et al.  Polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in the general population in Finland. , 2005, Chemosphere.

[34]  A. Lawrence,et al.  Reward processing in health and Parkinson's disease: neural organization and reorganization. , 2004, Cerebral cortex.

[35]  J. Holton,et al.  Hypothalamic α‐synuclein and its relation to weight loss and autonomic symptoms in Parkinson's disease , 2017, Movement disorders : official journal of the Movement Disorder Society.

[36]  C. Mazzà,et al.  Free‐living monitoring of Parkinson's disease: Lessons from the field , 2016, Movement disorders : official journal of the Movement Disorder Society.

[37]  M. Vassallo,et al.  Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade). , 2006, Parkinsonism & related disorders.

[38]  S. Zimmerman,et al.  Gender Differences in Mortality After Hip Fracture: The Role of Infection , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  P. Patil,et al.  The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease. , 2013, Parkinsonism & related disorders.

[40]  S. Rehncrona,et al.  Multicenter study on deep brain stimulation in Parkinson's disease: An independent assessment of reported adverse events at 4 years , 2008, Movement disorders : official journal of the Movement Disorder Society.

[41]  J. Morley,et al.  Assessment of protein energy malnutrition in older persons, Part II: Laboratory evaluation. , 2000, Nutrition.

[42]  K. Westerterp,et al.  Free‐living energy expenditure reduced after deep brain stimulation surgery for Parkinson’s disease , 2012, Clinical physiology and functional imaging.

[43]  L. Schiffer,et al.  Aromatic amino acids and modification of parkinsonism. , 1967, The New England journal of medicine.

[44]  H. Berendse,et al.  Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell , 2001, Annals of neurology.

[45]  E. Quigley,et al.  Gastroparesis and Parkinson's disease: a systematic review. , 2012, Parkinsonism & related disorders.

[46]  I Litvan,et al.  Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. , 2001, Archives of neurology.

[47]  C. McIntyre,et al.  Sources and effects of electrode impedance during deep brain stimulation , 2006, Clinical Neurophysiology.

[48]  Michael Camilleri,et al.  Methods for the assessment of small-bowel and colonic transit. , 2012, Seminars in nuclear medicine.

[49]  Kelly L. Sullivan,et al.  Levodopa-induced Dyskinesia in Parkinson’s disease: Epidemiology, etiology, and treatment , 2007, Current neurology and neuroscience reports.

[50]  E. Poehlman A review: exercise and its influence on resting energy metabolism in man. , 1989, Medicine and science in sports and exercise.

[51]  D. Brooks,et al.  Extrastriatal monoamine neuron function in Parkinson’s disease: An 18F-dopa PET study , 2008, Neurobiology of Disease.

[52]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[53]  P. Krack,et al.  Mechanisms of Body Weight Fluctuations in Parkinson’s Disease , 2014, Front. Neurol..

[54]  B. Bloem,et al.  Body mass index in Parkinson's disease: a meta-analysis. , 2012, Parkinsonism & related disorders.

[55]  C. A. Álvarez Marcos,et al.  Swallowing disorders in Parkinson's disease. , 2017, Acta otorrinolaringologica espanola.

[56]  E. Oh,et al.  Relationship between changes of body mass index (BMI) and cognitive decline in Parkinson's disease (PD). , 2012, Archives of gerontology and geriatrics.

[57]  C. Tanner,et al.  Bowel movement frequency in late‐life and incidental Lewy bodies , 2007, Movement disorders : official journal of the Movement Disorder Society.

[58]  S. Chung,et al.  Factors contributing to malnutrition in patients with Parkinson's disease. , 2016, International journal of nursing practice.

[59]  M. Canesi,et al.  Is underweightness still a major problem in Parkinson's disease patients? , 2003, European Journal of Clinical Nutrition.

[60]  R. Iacono,et al.  The hypothalamus in Parkinson Disease , 1987, The Italian Journal of Neurological Sciences.

[61]  R. Rafal,et al.  Appetitive motivational deficits in individuals with Parkinson's Disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[62]  M. Thomas,et al.  Dysphagia, a reversible cause not to be forgotten. , 1995, Postgraduate medical journal.

[63]  J. H. Friedman,et al.  Fatigue in Parkinson's disease: a nine‐year follow‐up , 2001, Movement disorders : official journal of the Movement Disorder Society.

[64]  J. Llovet,et al.  Role of fructose-sorbitol malabsorption in the irritable bowel syndrome , 1991 .

[65]  L. Forsgren,et al.  Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study , 2011, Nutritional neuroscience.

[66]  E. Cuny,et al.  Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight , 2004, Movement disorders : official journal of the Movement Disorder Society.

[67]  E. Bézard,et al.  Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms , 2009, The Lancet Neurology.

[68]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[69]  L. Provinciali,et al.  Rest energy expenditure in Parkinson's disease: role of disease progression and dopaminergic therapy. , 2013, Parkinsonism & related disorders.

[70]  Yunqi Xu,et al.  Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer’s Disease and Vascular Dementia: A Cross-Sectional Study , 2017, Front. Aging Neurosci..

[71]  M. Kołaczkowski,et al.  Sweet liking in patients with Parkinson's disease , 2013, Journal of the Neurological Sciences.

[72]  A. Gasbarrini,et al.  The role of small intestinal bacterial overgrowth in Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[73]  P. Mazzoni,et al.  Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease , 2016, Journal of Clinical Movement Disorders.

[74]  J. Johanson Review of the treatment options for chronic constipation. , 2007, MedGenMed : Medscape general medicine.

[75]  H. Berendse,et al.  Prevalence of smell loss in Parkinson's disease--a multicenter study. , 2009, Parkinsonism & related disorders.

[76]  M. Unosson,et al.  Factors of importance for weight loss in elderly patients with Parkinson's disease , 2004, Acta neurologica Scandinavica.

[77]  M. Mattson,et al.  Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice , 2014, Neurobiology of Aging.

[78]  S. Cummings,et al.  The association of Parkinson’s disease with bone mineral density and fracture in older women , 2008, Osteoporosis International.

[79]  J. Jankovic,et al.  Low Body Weight in Parkinson's Disease , 1992, Southern medical journal.

[80]  O. Tysnes,et al.  Loss of independence in early Parkinson disease , 2016, Neurology.

[81]  Dopaminergic agents and nutritional status in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[82]  A. Mauri,et al.  Mini Nutritional Assessment in patients with Parkinson's disease: correlation between worsening of the malnutrition and increasing number of disease-years , 2008, Nutritional neuroscience.

[83]  J. Ferreira,et al.  Dopamine agonist therapy in early Parkinson's disease. , 2008, The Cochrane database of systematic reviews.

[84]  R. Sakakibara,et al.  Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. , 2012, Brain : a journal of neurology.

[85]  Xiao-Ming Yin,et al.  Leptin Protects against 6-Hydroxydopamine-induced Dopaminergic Cell Death via Mitogen-activated Protein Kinase Signaling* , 2007, Journal of Biological Chemistry.

[86]  E. Cereda,et al.  Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson's disease outpatients hospitalised on a scheduled basis , 2012, British Journal of Nutrition.

[87]  H. Delemarre-van de Waal,et al.  Developmental programming of energy balance and its hypothalamic regulation. , 2011, Endocrine reviews.

[88]  C. Garrett,et al.  Locus Coeruleus Is Involved in Weight Loss in a Rat Model of Parkinson's Disease: An Effect Reversed by Deep Brain Stimulation , 2013, Brain Stimulation.

[89]  A. Melo,et al.  Is silent aspiration a risk factor for respiratory infection in Parkinson's disease patients? , 2008, Parkinsonism & related disorders.

[90]  Jian Liu,et al.  Noradrenergic lesion of the locus coeruleus increases the firing activity of the medial prefrontal cortex pyramidal neurons and the role of α2-adrenoceptors in normal and medial forebrain bundle lesioned rats , 2010, Brain Research.

[91]  M. Unosson,et al.  Food Habits and Intake of Nutrients in Elderly Patients with Parkinson’s Disease , 2006, Gerontology.

[92]  S. Fahn,et al.  Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint , 1999, Movement disorders : official journal of the Movement Disorder Society.

[93]  A. Lang,et al.  Practical application of a low‐protein diet for Parkinson's disease , 1988, Neurology.

[94]  G. Kerr,et al.  Malnutrition in a Sample of Community-Dwelling People with Parkinson’s Disease , 2012, PloS one.

[95]  M. Yamasaki,et al.  The thermic response to food intake in persons with thoracic spinal cord injury , 2016, Journal of physical therapy science.

[96]  K. Berridge,et al.  What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? , 1998, Brain Research Reviews.

[97]  E. Cereda,et al.  Low‐protein and protein‐redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review , 2010, Movement disorders : official journal of the Movement Disorder Society.

[98]  P. Hogarth,et al.  Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. , 2005, Archives of neurology.

[99]  P. Garcia-Lorda,et al.  Effect of oral administration of a whole formula diet on nutritional and cognitive status in patients with Alzheimer's disease. , 2005, Clinical nutrition.

[100]  Dag Aarsland,et al.  Depression in Parkinson disease—epidemiology, mechanisms and management , 2011, Nature Reviews Neurology.

[101]  Jungsu S. Oh,et al.  Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease , 2016, Neurobiology of Aging.

[102]  G. Linazasoro,et al.  Classifying risk factors for dyskinesia in Parkinson's disease. , 2010, Parkinsonism & related disorders.

[103]  Graham K Kerr,et al.  Prevalence of malnutrition in Parkinson's disease: a systematic review. , 2011, Nutrition reviews.

[104]  J. Péron,et al.  Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[105]  O. Rascol,et al.  Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson’s Disease , 2010, CNS drugs.

[106]  R. Munhoz,et al.  The differential diagnoses of parkinsonism: Findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics , 2010, Clinical Neurology and Neurosurgery.

[107]  Z. Mari,et al.  Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1. , 2016, JAMA neurology.

[108]  J W Langston,et al.  The hypothalamus in parkinson disease , 1978, Annals of neurology.

[109]  J. Cauley,et al.  Association Between Parkinson's Disease and Low Bone Density and Falls in Older Men: The Osteoporotic Fractures in Men Study , 2005, Journal of the American Geriatrics Society.

[110]  P. Ritz,et al.  IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. , 2007, The journal of nutrition, health & aging.

[111]  E. Quigley,et al.  Gastrointestinal symptoms in Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.

[112]  J. Lefaucheur,et al.  Low level of ventricular CSF orexin-A is not associated with objective sleepiness in PD. , 2011, Sleep medicine.

[113]  B. Sidenvall,et al.  Case studies of food shopping, cooking and eating habits in older women with Parkinson's disease. , 2001, Journal of advanced nursing.

[114]  Z. Andrews,et al.  Therapeutic Advances in Endocrinology and Metabolism Review , 2022 .

[115]  J. Salamone,et al.  Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine , 2002, Behavioural Brain Research.

[116]  Marilena Aiello,et al.  Body weight and food intake in Parkinson's disease. A review of the association to non-motor symptoms , 2015, Appetite.

[117]  C. Mariani,et al.  Body weight gain rate in patients with Parkinson's disease and deep brain stimulation , 2003, Movement disorders : official journal of the Movement Disorder Society.

[118]  A. Fasano,et al.  Gastrointestinal dysfunction in Parkinson's disease , 2003, The Lancet Neurology.

[119]  R. Doty,et al.  Olfactory dysfunction in parkinsonism , 1988, Neurology.

[120]  H. Reichmann,et al.  Reduced Body Mass Index in Parkinson’s Disease: Contribution of Comorbid Depression , 2013, The Journal of nervous and mental disease.

[121]  Adrian Danek,et al.  Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study , 2008, The Lancet Neurology.

[122]  E. Moro,et al.  Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease , 1999, Neurology.

[123]  J. Vardi,et al.  Weight loss in patients treated long-term with levodopa Metabolic aspects , 1976, Journal of the Neurological Sciences.

[124]  N. Teasdale,et al.  Predictors of weight loss in Parkinson's disease: Is weight loss the chicken or the egg? , 2007, Movement disorders : official journal of the Movement Disorder Society.

[125]  R. Paffenbarger,et al.  Body mass index and risk of Parkinson's disease: a prospective cohort study. , 2007, American journal of epidemiology.

[126]  R. Rodnitzky,et al.  Predictors of weight loss in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[127]  M. Emre,et al.  Cognitive impairment and dementia in Parkinson's disease: Practical issues and management , 2014, Movement disorders : official journal of the Movement Disorder Society.

[128]  J. Elmquist,et al.  Body weight is regulated by the brain: a link between feeding and emotion , 2005, Molecular Psychiatry.

[129]  R. Palmiter,et al.  Reward without Dopamine , 2003, The Journal of Neuroscience.

[130]  L. Królicki,et al.  Small intestine dysfunction in Parkinson’s disease , 2015, Journal of Neural Transmission.

[131]  H. Berendse,et al.  Idiopathic hyposmia as a preclinical sign of Parkinson's disease , 2004, Annals of neurology.

[132]  David J. Brooks,et al.  Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study , 2008, Experimental Neurology.

[133]  Yong-Jie Li,et al.  Cognitive and Psychiatric Effects of STN versus GPi Deep Brain Stimulation in Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials , 2016, PloS one.

[134]  C. Adler,et al.  Serum leptin concentrations and satiety in Parkinson's disease patients with and without weight loss , 2001, Movement disorders : official journal of the Movement Disorder Society.

[135]  I. Miyai,et al.  [Relationship between weight loss and dysphagia in patients with Parkinson's disease]. , 1999, Rinsho shinkeigaku = Clinical neurology.

[136]  V. De Rosa,et al.  Role of metabolism in neurodegenerative disorders. , 2016, Metabolism: clinical and experimental.

[137]  R. Walker,et al.  A cross-sectional study of the nutritional status of community-dwelling people with idiopathic Parkinson's disease , 2010, BMC neurology.

[138]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[139]  J. Speakman,et al.  Metabolic changes over the course of aging in a mouse model of tau deposition , 2016, Neurobiology of Aging.

[140]  B. Bloem,et al.  Parkinson's disease and osteoporosis. , 2013, Age and ageing.

[141]  R. Strong,et al.  Cognitive Dysfunction Precedes the Onset of Motor Symptoms in the MitoPark Mouse Model of Parkinson’s Disease , 2013, PloS one.

[142]  R. Strowd,et al.  Weight change following deep brain stimulation for movement disorders , 2010, Journal of Neurology.

[143]  W. Slade,et al.  Megacolon and dilatation of the small bowel in parkinsonism. , 1951, Gastroenterology.

[144]  E. Růžička,et al.  Subthalamic nucleus stimulation affects incentive salience attribution in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[145]  T. Iacono,et al.  Weight, nutrition, food choice, and physical activity in adults with intellectual disability. , 2016, Journal of intellectual disability research : JIDR.

[146]  R. Maxwell,et al.  Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery. , 2005, Parkinsonism & related disorders.

[147]  R. Pahwa,et al.  Olfactory function in essential tremor , 1992, Neurology.

[148]  C. Naylor,et al.  Parkinsonism in Ontario: Comorbidity associated with hospitalization in a large cohort , 2004, Movement disorders : official journal of the Movement Disorder Society.

[149]  D. Binder,et al.  Effects of Deep Brain Stimulation on Autonomic Function , 2016, Brain sciences.

[150]  J. Schwalb,et al.  Comparison of dysphagia before and after deep brain stimulation in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[151]  A. Zapf,et al.  Dopaminergic treatment is associated with decreased body weight in patients with Parkinson’s disease and dyskinesias , 2009, European journal of neurology.

[152]  J. Sharma,et al.  Olfaction, dyskinesia and profile of weight change in Parkinson's disease: identifying neurodegenerative phenotypes. , 2012, Parkinsonism & related disorders.

[153]  S. L. la Fleur,et al.  Subthalamic nucleus stimulation does not influence basal glucose metabolism or insulin sensitivity in patients with Parkinson's disease , 2014, Front. Neurosci..

[154]  Brittany D. Walls,et al.  Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson’s Disease: A Meta-Analysis , 2015, Neuropsychology Review.

[155]  M. Rodríguez-Violante,et al.  Overweight is more prevalent in patients with Parkinson's disease. , 2012, Arquivos de neuro-psiquiatria.

[156]  Y. Agid,et al.  Biochemistry of the hypothalamus in Parkinson's disease , 1984, Neurology.

[157]  M. Vassallo,et al.  Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype. , 2014, Neurodegenerative disease management.

[158]  J. Sellin,et al.  Review article: small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea , 2009, Alimentary pharmacology & therapeutics.

[159]  B. Tang,et al.  Simvastatin Induces Neuroprotection in 6‐OHDA‐Lesioned PC12 via the PI3K/AKT/Caspase 3 Pathway and Anti‐Inflammatory Responses , 2013, CNS neuroscience & therapeutics.

[160]  D. Ricquier Fundamental mechanisms of thermogenesis. , 2006, Comptes rendus biologies.

[161]  M. Okun,et al.  Swallowing and deep brain stimulation in Parkinson's disease: a systematic review. , 2013, Parkinsonism & related disorders.

[162]  R. Lister,et al.  Oropharyngeal dysphagia and nutritional management , 2006, Current opinion in gastroenterology.

[163]  S. Sherman,et al.  Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[164]  E. Huang,et al.  Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly. , 2016, The American journal of pathology.

[165]  M. Okun,et al.  Swallowing Outcomes Following Unilateral STN vs. GPi Surgery: A Retrospective Analysis , 2014, Dysphagia.

[166]  A. Dunn,et al.  Chronic alterations in jejunal myoelectric activity in rats due to MPTP. , 1987, The American journal of physiology.

[167]  R. Djaldetti,et al.  Gastric emptying in Parkinson's disease , 1996, Neurology.

[168]  Emmanuel Cuny,et al.  Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson's disease , 2005, British Journal of Nutrition.

[169]  H. Reichmann,et al.  Chocolate consumption is increased in Parkinson’s disease , 2009, Journal of Neurology.

[170]  A. Tomkins,et al.  Increased prevalence of undernutrition in Parkinson's disease and its relationship to clinical disease parameters , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[171]  Marjan Jahanshahi,et al.  Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability. , 2006, Parkinsonism & related disorders.

[172]  D. Brooks Safety and tolerability of COMT inhibitors , 2004, Neurology.

[173]  L. Bour,et al.  Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial , 2013, The Lancet Neurology.

[174]  C. Colosimo,et al.  Constipation: an emerging risk factor for Parkinson's disease? , 2016, European journal of neurology.

[175]  A. Krygowska-Wajs,et al.  The effect of subthalamic deep brain stimulation on gastric motility in Parkinson's disease. , 2016, Parkinsonism & related disorders.

[176]  Carmen Rodriguez-Blazquez,et al.  Burden, perceived health status, and mood among caregivers of Parkinson's disease patients , 2008, Movement disorders : official journal of the Movement Disorder Society.

[177]  P. Derost,et al.  Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation. , 2007, Brain : a journal of neurology.

[178]  C. Trenkwalder,et al.  Body weight in patients with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[179]  D. Bowers,et al.  Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE Trial , 2009, Annals of neurology.

[180]  P J Garry,et al.  The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. , 1999, Nutrition.

[181]  E. Wolińska-Witort,et al.  Leptin and ghrelin concentrations and weight loss in Parkinson’s disease , 2010, Acta neurologica Scandinavica.

[182]  R. Fisher,et al.  American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. , 2004, Gastroenterology.

[183]  D. Michalek,et al.  Weight change and body composition in patients with Parkinson's disease. , 1995, Journal of the American Dietetic Association.

[184]  E. Růžička,et al.  Sex, Food and Threat: Startling Changes after Subthalamic Stimulation in Parkinson's Disease , 2013, Brain Stimulation.

[185]  C. Leitão,et al.  Determinants of body weight regulation in humans. , 2016, Archives of endocrinology and metabolism.

[186]  Ying Wang,et al.  Malnutrition and associated factors in Chinese patients with Parkinson's disease: Results from a pilot investigation. , 2010, Parkinsonism & related disorders.

[187]  J. Jankovic,et al.  Weight gain following unilateral pallidotomy in Parkinson's disease , 2000, Acta neurologica Scandinavica.

[188]  A. Kupsch,et al.  Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson’s disease , 2008, European Journal of Clinical Pharmacology.

[189]  G. Kerr,et al.  Markers of Disease Severity Are Associated with Malnutrition in Parkinson's Disease , 2013, PloS one.

[190]  F. Durif,et al.  Parkinson's disease: A risk factor for osteoporosis. , 2015, Joint, bone, spine : revue du rhumatisme.

[191]  G. Kerr,et al.  Improved nutritional status is related to improved quality of life in Parkinson’s disease , 2014, BMC Neurology.

[192]  M. Mazzola,et al.  Body mass index does not change before Parkinson’s disease onset , 2008, European journal of neurology.

[193]  A. Tomkins,et al.  Diet, body size and micronutrient status in Parkinson's disease. , 1992, European journal of clinical nutrition.

[194]  A. Tomkins,et al.  Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity. , 1992, Clinical science.

[195]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment , 2009, The Lancet Neurology.

[196]  K. Hanew,et al.  The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects. , 2002, European journal of endocrinology.

[197]  A L Benabid,et al.  Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: A consecutive series of 62 patients , 1999, Annals of neurology.

[198]  L. T. Robertson,et al.  Site of deep brain stimulation and jaw velocity in Parkinson disease. , 2011, Journal of neurosurgery.

[199]  L. Forsgren,et al.  Weight gain and increased central obesity in the early phase of Parkinson's disease. , 2014, Clinical nutrition.

[200]  B. Bloem,et al.  Weight loss in neurodegenerative disorders , 2008, Journal of Neurology.

[201]  A. Gasbarrini,et al.  Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[202]  S. Fereshtehnejad,et al.  Mini Nutritional Assessment (MNA) is Rather a Reliable and Valid Instrument to Assess Nutritional Status in Iranian Healthy Adults and Elderly with a Chronic Disease , 2015, Ecology of food and nutrition.

[203]  S. Fereshtehnejad,et al.  Prevalence of malnutrition in patients with Parkinson's disease: a comparative study with healthy controls using Mini Nutritional Assessment (MNA) questionnaire. , 2014, Journal of Parkinson's disease.

[204]  Stuart Maudsley,et al.  Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. , 2012, Current Alzheimer research.

[205]  M. Trail,et al.  Daily energy expenditure, physical activity, and weight loss in Parkinson's disease patients , 2009, Movement disorders : official journal of the Movement Disorder Society.

[206]  S. Fox,et al.  Small intestinal bacterial overgrowth in Parkinson's disease. , 2014, Parkinsonism & related disorders.

[207]  Bin Wu,et al.  Influence of deep brain stimulation of the subthalamic nucleus on cognitive function in patients with Parkinson’s disease , 2013, Neuroscience Bulletin.

[208]  Ho-Won Lee,et al.  Weight Change Is a Characteristic Non-Motor Symptom in Drug-Naïve Parkinson’s Disease Patients with Non-Tremor Dominant Subtype: A Nation-Wide Observational Study , 2016, PloS one.

[209]  A. Quattrone,et al.  Body Weight Influences Pharmacokinetics of Levodopa in Parkinson's Disease , 2002, Clinical neuropharmacology.

[210]  N. Diederich,et al.  Contributory Factors to Caregiver Burden in Parkinson Disease. , 2016, Journal of the American Medical Directors Association.

[211]  D. Burke,et al.  The response to muscle stretch and shortening in Parkinsonian rigidity. , 1972, Brain : a journal of neurology.